Strategic Acquisition Carevive was acquired by Health Catalyst in June 2024, indicating potential integration opportunities with Health Catalyst’s broader healthcare analytics and data tools to expand joint offerings for oncology and patient experience.

Oncology Focus Specialization in oncology and patient-reported outcomes presents a clear path for upsell to cancer centers and integrated delivery networks seeking robust ePRO and symptom monitoring to improve survival outcomes and patient quality of life.

Global Language Lead Recent expansion includes a Spanish language version of remote patient monitoring workflows, highlighting a scalable, multilingual platform ideal for expanding into diverse markets and international health systems.

Clinical Data Leveraging Advanced data collection from real-world patient experiences via ePROs can be positioned as a differentiator for cancer drug development programs and outcomes research, appealing to biopharma and academic collaborations.

Strong Validation NCI-funded research initiatives and a recognition as a fast-track NCI contract recipient bolster credibility with potential customers and grant-funded projects, supporting procurement conversations and risk assessment for deployments.